Brief: Curevac Receives Positive Validity Decision From European Patent Office In Litigation Against Biontech SE
27/03/2025 20:07
March 27 (Reuters) - CureVac NV 5CV.DE: EQS-NEWS: CUREVAC RECEIVES POSITIVE VALIDITY DECISION FROM EUROPEAN PATENT OFFICE IN LITIGATION AGAINST BIONTECH SE Source text: ID:nEQ8SkzBya Further company coverage: 5CV.DE ((reuters.briefs@thomsonreuters.com;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028